NCI

December 12, 2013

Therapeutic target for gastric cancer

A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies.

By Leigh MacMillan
December 12, 2013

VU study points to central regulator of neuron development

Developmental biologist Chin Chiang, Ph.D., and his colleagues have discovered that Purkinje neurons in the cerebellum act as central regulators of neuronal development.

By Leigh MacMillan
December 5, 2013

Research climate must be enhanced: NCI director

The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States.

By Leigh MacMillan
November 21, 2013

Therapeutic target for synovial sarcoma

Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.

By Leigh MacMillan
November 14, 2013

National Cancer Institute director set for Discovery Lecture

The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.

By Leigh MacMillan
November 13, 2013

Molecular circuits in ovarian cancer

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.

By Leigh MacMillan
November 7, 2013

Breast SPORE lands NCI renewal

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI).
By VUMC News and Communications
November 7, 2013

VU study sheds new light on DNA replication

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.
By Leigh MacMillan
October 25, 2013

Targets of SIN drive cell division

Vanderbilt researchers have identified a key regulator of cell division.
By Leigh MacMillan
October 14, 2013

Magnesium impacts vitamin D status

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer.
By VUMC News and Communications
October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
By Leigh MacMillan
September 26, 2013

Cell changes en route to stomach cancer

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.
By Leigh MacMillan
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
By Leigh MacMillan
1 … 18 19 20 21 22 … 28